Certuity LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.4% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 2,880 shares of the company’s stock after selling 163 shares during the period. Certuity LLC’s holdings in Cardinal Health were worth $341,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp grew its holdings in shares of Cardinal Health by 4.6% in the third quarter. State Street Corp now owns 14,177,641 shares of the company’s stock valued at $1,566,913,000 after acquiring an additional 627,253 shares in the last quarter. Geode Capital Management LLC boosted its position in Cardinal Health by 0.7% in the third quarter. Geode Capital Management LLC now owns 5,749,859 shares of the company’s stock worth $633,298,000 after purchasing an additional 42,082 shares during the last quarter. Pacer Advisors Inc. grew its stake in Cardinal Health by 4.7% in the 3rd quarter. Pacer Advisors Inc. now owns 4,290,650 shares of the company’s stock valued at $474,203,000 after purchasing an additional 191,568 shares during the period. Charles Schwab Investment Management Inc. increased its position in shares of Cardinal Health by 2.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,474,625 shares of the company’s stock valued at $162,976,000 after purchasing an additional 33,388 shares during the last quarter. Finally, Two Sigma Advisers LP raised its stake in shares of Cardinal Health by 47.9% during the 3rd quarter. Two Sigma Advisers LP now owns 1,069,462 shares of the company’s stock worth $118,197,000 after purchasing an additional 346,362 shares during the period. Hedge funds and other institutional investors own 87.17% of the company’s stock.
Wall Street Analyst Weigh In
Several research firms recently weighed in on CAH. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and increased their price target for the company from $132.00 to $145.00 in a research report on Monday, January 6th. UBS Group lifted their price target on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a report on Monday, November 4th. JPMorgan Chase & Co. upped their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a research note on Tuesday, February 4th. StockNews.com downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Sunday, November 3rd. Finally, Morgan Stanley upped their price target on Cardinal Health from $136.00 to $142.00 and gave the company an “overweight” rating in a research report on Friday, January 31st. Four analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. Based on data from MarketBeat, Cardinal Health presently has an average rating of “Moderate Buy” and an average price target of $136.87.
Cardinal Health Stock Down 1.0 %
CAH stock opened at $127.09 on Thursday. Cardinal Health, Inc. has a twelve month low of $93.17 and a twelve month high of $132.84. The firm has a market capitalization of $30.70 billion, a PE ratio of 23.71, a PEG ratio of 1.49 and a beta of 0.63. The stock has a 50-day simple moving average of $122.69 and a two-hundred day simple moving average of $115.91.
Cardinal Health (NYSE:CAH – Get Free Report) last posted its earnings results on Thursday, January 30th. The company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, equities research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.
Cardinal Health Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be given a $0.5056 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $2.02 dividend on an annualized basis and a dividend yield of 1.59%. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.
Cardinal Health Profile
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Further Reading
- Five stocks we like better than Cardinal Health
- 3 Warren Buffett Stocks to Buy Now
- 3 Reasons Micron Stock Is Deeply Undervalued Right Now
- 5 discounted opportunities for dividend growth investors
- Inflation Persists, But So Do Stock Opportunities: Rally On
- How to Start Investing in Real Estate
- Energy Transfer Fuels the Cloud: A Natural Gas Power Play
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.